Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of patients develop recurrent disease. Physical activity has emerged as a potential lifestyle intervention to reduce cancer recurrence and improve survival among people with colon cancer (CC). This pilot study aims to identify the dose-response effects of aerobic exercise on molecular and cellular pathways associated with physical activity and CC outcomes among patients with stage II and III CC.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Enrollment
44
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
1. The biological efficacy of aerobic exercise on soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular adhesion molecule-1 (sVCAM-1) prognostic biomarkers.
Time frame: 2 years
Exercise adherence, quantified as the percentage of total dose completed relative to the total dose prescribed during the six-month study;
Time frame: 6 months
Visceral adipose tissue and anthropometric measures at baseline and six-months;
Time frame: 6 months
Fasting insulin measured at baseline and six-months;
Time frame: six months
Circulating tumor cells measured at baseline and six-months.
Time frame: six months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.